MolNFT v1 · #76415 · protein
Crystal structure of human beta-crystallin B3
3QK3: “Crystal structure of human beta-crystallin B3”. X-ray diffraction, 1 ligand (SO4), 3 pockets (best druggability 0.88). MolNFT v1 #76415 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 3QK3
- Type
- protein
- Length
- 527 residues
- Chains
- 3
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Beta-crystallin B3
- UniProt
- P26998
- Ligands
- SO4
- Pockets
- 3 · best druggability 0.88
Structure
x-ray diffraction · 2 distinct chains · 9% helix, 43% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Beta-crystallin B3 | protein | 175 | 10% helix, 42% strand | P26998 |
| B, C | Beta-crystallin B3 | protein | 176 | 9% helix, 44% strand | P26998 |
Ligands and binding sites
- SO4 · Sulfate ion · ion · 5 copies · chains A, B, C
- EDO · 1,2-ethanediol · additive · 5 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 1145 | 0.88 | 0.89 | 114 | SO4 |
| 2 | 109 | 0.45 | 0.79 | 22 | empty |
| 3 | 101 | 0.42 | 0.77 | 18 | empty |
Interfaces
3 interfaces between chains.
- A–B · 763 Ų buried · 19 hydrogen bonds · protein-protein
- A–C · 697 Ų buried · 16 hydrogen bonds · protein-protein
- B–C · 515 Ų buried · 9 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P26998
- Elsewhere: RCSB PDB 3QK3 · PDBe 3QK3 · UniProt P26998
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.